큐렉소
Financials
Valuation Metrics
큐렉소's Market Cap is ₩2917B. At end of 2025 it was ₩5347B. Ranked #621 of 2,405 in KR market (top 26%), #255 of 1,627 on KOSDAQ (top 16%), #6 of 10 in Consumer Staples Distribution & Retail (top 60%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 291.71B KRW | KR#621/2,405 Sec#6/10 |
| Revenue | 77.74B KRW | KR#1,556/2,405 Sec#10/10 |
| Net Income | 5.51B KRW | KR#1,170/2,405 Sec#8/10 |
| Total Assets | 111.45B KRW | KR#1,688/2,405 Sec#9/10 |
| Net Assets | 100.88B KRW | KR#1,406/2,405 Sec#8/10 |
| Employees | 99 | KR#1,639/2,405 Sec#7/10 |
| Value | ||
| P/E | 52.93x | KR#1,429/2,405 Sec#9/10 |
| P/B | 2.89x | KR#2,126/2,405 Sec#10/10 |
| P/S | 3.75x | KR#2,076/2,405 Sec#9/10 |
| EV/EBITDA | 84.80x | KR#1,470/2,405 Sec#10/10 |
| FCF Yield | -4.71% | KR—/2,405 Sec—/10 |
| Profitability | ||
| ROE | 5.46% | KR#1,044/2,405 Sec#7/10 |
| ROA | 4.95% | KR#744/2,405 Sec#5/10 |
| Op. Margin | 4.18% | KR#1,068/2,405 Sec#5/10 |
| Revenue Growth | 20.38% | KR#539/2,405 Sec#2/10 |
| Financial Health | ||
| Debt Ratio | 10.48% | KR#154/2,405 Sec#2/10 |
| Total Debt | 414.3M KRW | KR#1,990/2,405 Sec#10/10 |
| FCF | -13.74B KRW | KR#1,792/2,405 Sec#10/10 |
| Cash | 16.71B KRW | KR#1,367/2,405 Sec#10/10 |
| Current Ratio | 10.09x | KR#96/2,405 Sec#2/10 |
| Net Debt/EBITDA | -5.02x | KR#103/2,405 Sec#1/10 |
| Performance | ||
| 1Y Return | -32.99% | KR#1,635/2,405 Sec#9/10 |
| 1M Return | -19.48% | KR#1,846/2,405 Sec#10/10 |
| From 52W High | -68.65% | KR#2,013/2,405 Sec#10/10 |
| 1Y MDD | -65.26% | KR#1,729/2,405 Sec#10/10 |
| Trading | ||
| Volume | 101,826 shares | KR#619/2,405 Sec#3/10 |
| Trading Value | 722.5M KRW | KR#679/2,405 Sec#5/10 |
| Foreign Own. | 5.14% | KR#838/2,405 Sec#6/10 |
| Per Share | ||
| EPS | 134 KRW | KR#1,383/2,405 Sec#9/10 |
| BPS | 2,445 KRW | KR#1,979/2,405 Sec#9/10 |
Company Info
Established in 1992 and listed on KOSDAQ in 2002, this company is a specialized medical robot enterprise, planning global business expansion with a local subsidiary in India by 2025. Its medical robot business division operates the orthopedic surgical robot CUVIS-Joint, rehabilitation treatment robot Morning Walk, artificial joint prosthesis implant business, and food ingredient trading. The company addresses the demand for rehabilitation robots driven by an aging population, expands its product range through contracts with US implant specialized enterprises, and pursues medical robot technology innovation and business diversification. Curexo, established in 1992, is headquartered in Seoul Metropolitan City, Songpa-gu.